Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)
Condition(s):Silicosis TuberculosisLast Updated:April 5, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Silicosis TuberculosisLast Updated:April 5, 2019Unknown status
Condition(s):TuberculosisLast Updated:January 25, 2022Unknown status
Condition(s):Tuberculosis; HIV InfectionsLast Updated:February 6, 2014Completed
Condition(s):Erythropoietic Protoporphyria (EPP); X Linked Erythropoietic ProtoporphyriaLast Updated:January 16, 2017Terminated
Condition(s):HIV Seropositivity; Pregnancy; Tuberculosis InfectionLast Updated:December 12, 2022Not yet recruiting
Condition(s):Tuberculosis; HIVLast Updated:October 30, 2019Completed
Condition(s):Compliance, PatientLast Updated:October 12, 2023Terminated
Condition(s):Pulmonary TuberculosisLast Updated:February 28, 2011Terminated
Condition(s):Latent Tuberculosis InfectionLast Updated:December 15, 2016Unknown status
Condition(s):Tuberculosis; Drug-Induced Liver Injury; Adverse Drug EventLast Updated:February 28, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.